This report contains market size and forecasts of Squamous Non-Small Cell Lung Cancer Therapeutics in Global, including the following market information:
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Squamous Non-Small Cell Lung Cancer Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Squamous Non-Small Cell Lung Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Segment Percentages, By Type, 2020 (%)
BMS-906024
Buparlisib Hydrochloride
FP-1039
Ipilimumab
JNJ-42756493
Lenvatinib
Others
China Squamous Non-Small Cell Lung Cancer Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Squamous Non-Small Cell Lung Cancer Therapeutics Market Segment Percentages, By Application, 2020 (%)
Research Center
Hospital
Clinic
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Squamous Non-Small Cell Lung Cancer Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Squamous Non-Small Cell Lung Cancer Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Genentech, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
Oncogenex Pharmaceuticals, Inc.
PsiOxus Therapeutics Limited
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Overall Market Size
2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size: 2021 VS 2027
2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Squamous Non-Small Cell Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Squamous Non-Small Cell Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Squamous Non-Small Cell Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Squamous Non-Small Cell Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Markets, 2021 & 2027
4.1.2 BMS-906024
4.1.3 Buparlisib Hydrochloride
4.1.4 FP-1039
4.1.5 Ipilimumab
4.1.6 JNJ-42756493
4.1.7 Lenvatinib
4.1.8 Others
4.2 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2021 & 2027
5.1.2 Research Center
5.1.3 Hospital
5.1.4 Clinic
5.2 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.3.2 US Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.3.3 Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.3.4 Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.4.2 Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.3 France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.4 U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.5 Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.6 Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.8 Benelux Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.4 South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.6 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.6.2 Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.6.3 Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.7.2 Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.3 Israel Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.5 UAE Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Ascenta Therapeutics, Inc.
7.1.1 Ascenta Therapeutics, Inc. Corporate Summary
7.1.2 Ascenta Therapeutics, Inc. Business Overview
7.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.1.4 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.1.5 Ascenta Therapeutics, Inc. Key News
7.2 AstraZeneca Plc
7.2.1 AstraZeneca Plc Corporate Summary
7.2.2 AstraZeneca Plc Business Overview
7.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.2.4 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.2.5 AstraZeneca Plc Key News
7.3 AVEO Pharmaceuticals, Inc.
7.3.1 AVEO Pharmaceuticals, Inc. Corporate Summary
7.3.2 AVEO Pharmaceuticals, Inc. Business Overview
7.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.3.4 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.3.5 AVEO Pharmaceuticals, Inc. Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.4.5 Bayer AG Key News
7.5 BIND Therapeutics, Inc.
7.5.1 BIND Therapeutics, Inc. Corporate Summary
7.5.2 BIND Therapeutics, Inc. Business Overview
7.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.5.4 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.5.5 BIND Therapeutics, Inc. Key News
7.6 Boehringer Ingelheim GmbH
7.6.1 Boehringer Ingelheim GmbH Corporate Summary
7.6.2 Boehringer Ingelheim GmbH Business Overview
7.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.6.4 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim GmbH Key News
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Corporate Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.7.5 Bristol-Myers Squibb Company Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.8.4 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.8.5 Eli Lilly and Company Key News
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
7.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.9.5 F. Hoffmann-La Roche Ltd. Key News
7.10 Five Prime Therapeutics, Inc.
7.10.1 Five Prime Therapeutics, Inc. Corporate Summary
7.10.2 Five Prime Therapeutics, Inc. Business Overview
7.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.10.4 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.10.5 Five Prime Therapeutics, Inc. Key News
7.11 Genentech, Inc.
7.11.1 Genentech, Inc. Corporate Summary
7.11.2 Genentech, Inc. Business Overview
7.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.11.4 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.11.5 Genentech, Inc. Key News
7.12 Incyte Corporation
7.12.1 Incyte Corporation Corporate Summary
7.12.2 Incyte Corporation Business Overview
7.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.12.4 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.12.5 Incyte Corporation Key News
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Corporate Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.13.4 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.13.5 Johnson & Johnson Key News
7.14 MacroGenics, Inc.
7.14.1 MacroGenics, Inc. Corporate Summary
7.14.2 MacroGenics, Inc. Business Overview
7.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.14.4 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.14.5 MacroGenics, Inc. Key News
7.15 Novartis AG
7.15.1 Novartis AG Corporate Summary
7.15.2 Novartis AG Business Overview
7.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.15.4 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.15.5 Novartis AG Key News
7.16 Oncogenex Pharmaceuticals, Inc.
7.16.1 Oncogenex Pharmaceuticals, Inc. Corporate Summary
7.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview
7.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.16.4 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.16.5 Oncogenex Pharmaceuticals, Inc. Key News
7.17 PsiOxus Therapeutics Limited
7.17.1 PsiOxus Therapeutics Limited Corporate Summary
7.17.2 PsiOxus Therapeutics Limited Business Overview
7.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.17.4 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.17.5 PsiOxus Therapeutics Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Squamous Non-Small Cell Lung Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers in Global Market
Table 3. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Squamous Non-Small Cell Lung Cancer Therapeutics in Global Market
Table 5. Top Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Squamous Non-Small Cell Lung Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Squamous Non-Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Genentech, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
Oncogenex Pharmaceuticals, Inc.
PsiOxus Therapeutics Limited
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)